These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 37891423)
1. Development of machine learning prognostic models for overall survival of prostate cancer patients with lymph node-positive. Peng ZH; Tian JH; Chen BH; Zhou HB; Bi H; He MX; Li MR; Zheng XY; Wang YW; Chong T; Li ZL Sci Rep; 2023 Oct; 13(1):18424. PubMed ID: 37891423 [TBL] [Abstract][Full Text] [Related]
2. Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer. Gandaglia G; Fossati N; Zaffuto E; Bandini M; Dell'Oglio P; Bravi CA; Fallara G; Pellegrino F; Nocera L; Karakiewicz PI; Tian Z; Freschi M; Montironi R; Montorsi F; Briganti A Eur Urol; 2017 Oct; 72(4):632-640. PubMed ID: 28412062 [TBL] [Abstract][Full Text] [Related]
3. External Validation of Models Predicting the Probability of Lymph Node Involvement in Prostate Cancer Patients. Hueting TA; Cornel EB; Somford DM; Jansen H; van Basten JA; Pleijhuis RG; Korthorst RA; van der Palen JAM; Koffijberg H Eur Urol Oncol; 2018 Oct; 1(5):411-417. PubMed ID: 31158080 [TBL] [Abstract][Full Text] [Related]
4. Development and external validation of a multivariable [ Muehlematter UJ; Schweiger L; Ferraro DA; Hermanns T; Maurer T; Heck MM; Rupp NJ; Eiber M; Rauscher I; Burger IA Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):3137-3146. PubMed ID: 37261472 [TBL] [Abstract][Full Text] [Related]
5. Assessing the risk of lymph node invasion in patients with intermediate risk prostate cancer treated with extended pelvic lymph node dissection. A novel prediction tool. Briganti A; Capitanio U; Abdollah F; Gallina A; Suardi N; Bianchi M; Tutolo M; Salonia A; Freschi M; Rigatti P; Montorsi F Prostate; 2012 Apr; 72(5):499-506. PubMed ID: 22468270 [TBL] [Abstract][Full Text] [Related]
6. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients. Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093 [TBL] [Abstract][Full Text] [Related]
7. Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion. Preisser F; Bandini M; Marchioni M; Nazzani S; Tian Z; Pompe RS; Fossati N; Briganti A; Saad F; Shariat SF; Heinzer H; Huland H; Graefen M; Tilki D; Karakiewicz PI Prostate; 2018 May; 78(6):469-475. PubMed ID: 29460290 [TBL] [Abstract][Full Text] [Related]
8. A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies. Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Fossati N; Stabile A; Beauval JB; Malavaud B; Roumiguié M; Robesti D; Dell'Oglio P; Moschini M; Zamboni S; Rakauskas A; De Cobelli F; Porpiglia F; Montorsi F; Briganti A Eur Urol; 2019 Mar; 75(3):506-514. PubMed ID: 30342844 [TBL] [Abstract][Full Text] [Related]
9. Increasing rate of lymph node invasion in patients with prostate cancer treated with radical prostatectomy and lymph node dissection. Preisser F; Nazzani S; Bandini M; Marchioni M; Tian Z; Montorsi F; Saad F; Briganti A; Steuber T; Budäus L; Huland H; Graefen M; Tilki D; Karakiewicz PI Urol Oncol; 2018 Aug; 36(8):365.e1-365.e7. PubMed ID: 29887241 [TBL] [Abstract][Full Text] [Related]
10. Predicting Colorectal Cancer Survival Using Time-to-Event Machine Learning: Retrospective Cohort Study. Yang X; Qiu H; Wang L; Wang X J Med Internet Res; 2023 Oct; 25():e44417. PubMed ID: 37883174 [TBL] [Abstract][Full Text] [Related]
11. Prediction of lung papillary adenocarcinoma-specific survival using ensemble machine learning models. Xia K; Chen D; Jin S; Yi X; Luo L Sci Rep; 2023 Sep; 13(1):14827. PubMed ID: 37684259 [TBL] [Abstract][Full Text] [Related]
12. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection. Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120 [TBL] [Abstract][Full Text] [Related]
13. Predictors of Lymph Node Invasion in Patients with Clinically Localized Prostate Cancer Who Undergo Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: The Role of Obesity. Tafuri A; Rizzetto R; Amigoni N; Sebben M; Shakir A; Gozzo A; Odorizzi K; Gallina S; Bianchi A; Ornaghi P; Brunelli M; Migliorini F; Cerruto MA; Artibani W; Siracusano S; Antonelli A; Porcaro AB Urol Int; 2021; 105(5-6):362-369. PubMed ID: 33059351 [TBL] [Abstract][Full Text] [Related]
14. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. Briganti A; Larcher A; Abdollah F; Capitanio U; Gallina A; Suardi N; Bianchi M; Sun M; Freschi M; Salonia A; Karakiewicz PI; Rigatti P; Montorsi F Eur Urol; 2012 Mar; 61(3):480-7. PubMed ID: 22078338 [TBL] [Abstract][Full Text] [Related]
15. Development and validation of machine learning models for predicting prognosis and guiding individualized postoperative chemotherapy: A real-world study of distal cholangiocarcinoma. Wang D; Pan B; Huang JC; Chen Q; Cui SP; Lang R; Lyu SC Front Oncol; 2023; 13():1106029. PubMed ID: 37007095 [TBL] [Abstract][Full Text] [Related]
16. A novel nomogram predicting lymph node invasion among patients with prostate cancer: The importance of extracapsular extension at multiparametric magnetic resonance imaging. Di Trapani E; Luzzago S; Peveri G; Catellani M; Ferro M; Cordima G; Mistretta FA; Bianchi R; Cozzi G; Alessi S; Matei DV; Bagnardi V; Petralia G; Musi G; De Cobelli O Urol Oncol; 2021 Jul; 39(7):431.e15-431.e22. PubMed ID: 33423938 [TBL] [Abstract][Full Text] [Related]
17. Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study. Steuber T; Budäus L; Walz J; Zorn KC; Schlomm T; Chun F; Ahyai S; Fisch M; Sauter G; Huland H; Graefen M; Haese A BJU Int; 2011 Jun; 107(11):1755-61. PubMed ID: 20942833 [TBL] [Abstract][Full Text] [Related]
18. First Nomogram Predicting the Probability of Lymph Node Involvement in Prostate Cancer Patients Undergoing Radioisotope Guided Sentinel Lymph Node Dissection. Winter A; Kneib T; Rohde M; Henke RP; Wawroschek F Urol Int; 2015; 95(4):422-8. PubMed ID: 26159232 [TBL] [Abstract][Full Text] [Related]
19. Optimization and validation of 18F-DCFPyL PET radiomics-based machine learning models in intermediate- to high-risk primary prostate cancer. Luining WI; Oprea-Lager DE; Vis AN; van Moorselaar RJA; Knol RJJ; Wondergem M; Boellaard R; Cysouw MCF PLoS One; 2023; 18(11):e0293672. PubMed ID: 37943772 [TBL] [Abstract][Full Text] [Related]